Initiative for innovative companies in Basel-Landschaft
A new initiative has been launched to support innovative SMEs and startups in the canton of Basel-Landschaft in an effort to make the region even more attractive and strengthen its ability to innovate. The initiative will offer both financial assistance and advisory services.
Entrepreneur with ideas (Img: Ollyy/shutterstock)
The “100 fürs Baselbiet” (100 for Basel-Landschaft) initiative is aimed at established SMEs or startups connected to the canton of Basel-Landschaft. Launched by the Basellandschaftliche Kantonalbank (BLKB), the University of Applied Sciences Northwestern Switzerland (FHNW) and the economic development agency of Baselland, the initiative aims to enable “100 companies with current or future value creation in the canton to take a decisive step forward in their development”. It will combine access to financial resources with advisory services.
“The initiative is an example of how we at BLKB understand sustainability and planning for the future,” said Beat Röthlisberger, head of corporate customary advisory services at BLKB. “We are breaking new ground in corporate financing to complement traditional lending, and we are addressing target groups beyond our core business.”
Companies that are interested in receiving support through the initiative can now apply online. Candidates will undergo a two-stage selection process, before a final decision is made by an advisory board. Successful applicants will receive a loan of between CHF 100,000 and CHF 500,000 at an “attractive interest rate depending on the risk” with a three-year term. During those three years, the companies will also receive advisory services from an initiative mentor and have access to the networks of BLKB and the economic development agency of Baselland.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More